Skip to content
Longterm Wiki
Back

The Looming Super-Bug Crisis: China's Battle Against Antimicrobial Resistance

web

This essay analyzes antimicrobial resistance (AMR) as a global catastrophic biosecurity risk, focusing on China's role. While not directly about AI safety, AMR represents a biosecurity threat relevant to AI safety researchers studying pandemic preparedness and global catastrophic risks.

Metadata

Importance: 18/100opinion pieceanalysis

Summary

This essay, submitted to a ChinaTalk contest on Manifund, argues there is a 40% chance of a broad-spectrum antibiotic-resistant superbug emerging from China by 2035. It examines China's unique AMR challenges including high rates of macrolide-resistant mycoplasma pneumoniae and the MCR-1 colistin-resistance gene. The piece frames AMR as a potential global catastrophic risk comparable to or exceeding COVID-19.

Key Points

  • Author estimates 40% probability of a broad-spectrum antibiotic-resistant superbug emerging from China by 2035.
  • China faces high AMR rates: 60-70% of adult and up to 80% of child mycoplasma pneumoniae cases are macrolide-resistant.
  • The MCR-1 gene, conferring resistance to last-resort antibiotic colistin, was identified in China in 2016.
  • AMR could make routine medical procedures like surgeries and minor injuries potentially fatal.
  • China's large population and global connectivity make it a critical focal point for global AMR surveillance.

Cached Content Preview

HTTP 200Fetched Apr 12, 202613 KB
The Looming Super-Bug Crisis | Manifund

 

 
 
 
 

 Oct
 NOV
 Dec
 

 
 

 
 19
 
 

 
 

 2024
 2025
 2026
 

 
 
 

 

 

 
 
success

 
fail

 
 
 
 
 
 
 
 
 
 
 

 

 
 
 
 
 
 
 
 
 

 

 About this capture
 

 

 

 

 

 

 
COLLECTED BY

 

 

 
 
Collection: Common Crawl

 

 

 Web crawl data from Common Crawl.
 

 

 

 

 

 
TIMESTAMPS

 

 

 

 

 

 

The Wayback Machine - http://web.archive.org/web/20251119094449/https://manifund.org/projects/the-looming-super-bug-crisis

 

Manifund

Home

Login

About

People

Categories

Newsletter

Home

About

People

Categories

Login

Create

1

The Looming Super-Bug Crisis

Science & technology

ChinaTalk Essay Contest

Biosecurity

Forecasting

Global catastrophic risks

Global health & development

Nick Ayrton

Complete

Impact certificate

$20raised

$200valuation

Sign in to trade

p]:prose-li:my-0 text-gray-900 prose-blockquote:text-gray-600 prose-a:font-light prose-blockquote:font-light font-light break-anywhere empty:prose-p:after:content-["\00a0"]">
 

The Looming Super-Bug Crisis: China's Battle Against Antimicrobial Resistance

As the world finally begins to step out of the shadow of the COVID pandemic, another global health emergency is at the doorstep. The emergence of super-bugs, or pathogens resistant to multiple antibiotics, poses an escalating challenge to global health with consequences that could rival or even surpass the previous pandemic. The phenomenon of antimicrobial resistance (AMR) has moved from a looming threat outside the realm of possibility to a completely plausible reality in which surgeries, car accidents, or even tattoos are deadly. 

The People's Republic of China, with its vast population and global connections, is at the forefront of this battle against AMR. The nation's unique set of challenges, from healthcare system issues to the high prevalence of resistant strains, places it under the microscope in the global effort to understand and combat the rise of super-bugs. With this in mind I argue that there is a 40% chance of a super-bug, resistant to a broad spectrum of antibiotics, emerging from China by the year 2035. 

Why Fear the Super-Bug

Super-bugs, a term broadly used for pathogens resistant to multiple antibiotics, pose a significant threat to public health and left unchecked, human civilization. These include resistant strains of bacteria, viruses, parasites, and fungi. Common examples are bacteria causing pneumonia, urinary tract infections, and skin infections. Drug resistance, or antimicrobial resistance (AMR), is a natural phenomenon wherein bacteria adapt to medications designed to eliminate them. The resistance is accelerated by the use of antibiotics, creating evolutionary pressure for bacteria to develop resistant forms.

In China, the rise of super-bugs has placed considerable strain on the healthcare system. A notable instance was a large wave of Mycoplasma pneumoniae infections in September of last year. This bacte

... (truncated, 13 KB total)
Resource ID: 56bb6b529195c9f4